Retour
Fourchette du Jour
7,75 €
8,30 €
Fourchette 52 Semaines
7,75 €
17,85 €
Volume
100
Moyenne 50J / 200J
9,79 €
/
11,04 €
Clôture Précédente
7,75 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -0,3 | 0,3 |
| P/B | 0,0 | 2,9 |
| ROE % | -6,9 | 3,7 |
| Net Margin % | -20,2 | 3,8 |
| Rev Growth 5Y % | 18,6 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
220,23 €
120,98 € – 342,51 €
|
79 B | 1 |
| FY2029 |
141,75 €
77,87 € – 220,45 €
|
61 B | 1 |
| FY2028 |
118,08 €
64,87 € – 183,64 €
|
53 B | 1 |
Points Clés
Revenue grew 18,61% annually over 5 years — strong growth
Earnings declined -124,99% over the past year
Debt/Equity of 0,33 — conservative balance sheet
Negative free cash flow of -14,93B
PEG of 0,54 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 78,90%
Croissance
Revenue Growth (5Y)
18,61%
Revenue (1Y)-60,29%
Earnings (1Y)-124,99%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-6,93%
ROIC-5,44%
Net Margin-20,24%
Op. Margin-26,86%
Sécurité
Debt / Equity
0,33
Current Ratio1,66
Interest Coverage-9,94
Valorisation
P/E Ratio
-0,27
P/B Ratio0,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -60,29% | Revenue Growth (3Y) | -16,91% |
| Earnings Growth (1Y) | -124,99% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 18,61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 18,54B | Net Income (TTM) | -3,75B |
| ROE | -6,93% | ROA | -4,87% |
| Gross Margin | 40,61% | Operating Margin | -26,86% |
| Net Margin | -20,24% | Free Cash Flow (TTM) | -14,93B |
| ROIC | -5,44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,33 | Current Ratio | 1,66 |
| Interest Coverage | -9,94 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -0,27 | P/B Ratio | 0,02 |
| P/S Ratio | 0,05 | PEG Ratio | 0,54 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,00B | Enterprise Value | -10,65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 18,54B | 46,68B | 26,85B | 9,37B | 11,68B |
| Net Income | -3,75B | 15,01B | 7,55B | 3,61B | 4,45B |
| EPS (Diluted) | -29,80 | 115,68 | 58,14 | 19,81 | 34,26 |
| Gross Profit | 7,53B | 34,50B | 18,11B | 7,01B | 9,53B |
| Operating Income | -4,98B | 21,11B | 8,98B | 4,42B | 6,99B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 77,10B | 92,77B | 63,87B | 26,62B | 26,27B |
| Total Liabilities | 25,53B | 36,01B | 31,82B | 1,62B | 5,05B |
| Shareholders' Equity | 51,57B | 56,76B | 32,04B | 25,00B | 21,22B |
| Total Debt | 17,06B | 19,63B | 21,05B | 0,0 | 0,0 |
| Cash & Equivalents | 28,71B | 48,12B | 5,25B | 11,75B | 7,15B |
| Current Assets | 38,95B | 57,21B | 25,07B | 13,86B | 15,64B |
| Current Liabilities | 23,44B | 18,41B | 11,03B | 1,27B | 4,71B |